CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Chugai Seiyaku Kabushiki Kaisha against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Tgfbeta1-Binding Immunoglobulins And Use ThereofSCHOLAR ROCKFeb 16, 2024
Compositions And Methods For Growth Factor ModulationSCHOLAR ROCKJun 1, 2021
Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding ReagentsBOEHRINGER INGELHEIMFeb 26, 2021

Explore Chugai Seiyaku Kabushiki Kaisha's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 25, 2024Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance1
Jun 19, 2024Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion1
May 8, 2024Method For The Production Of A Glycosylated Immunoglobulin1
Dec 6, 2023Pharmaceutical Composition Containing Poorly-Soluble Basic Medicine2
Nov 15, 2023Fc Riib-Specific Fc Antibody1
Oct 11, 2023Non-Human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 Gene1
Nov 2, 2022Method For Measuring Reactivity Of Fviii2
Oct 26, 2022Antitumor T Cell Response Enhancer1
Apr 6, 2022Method For Purifying Composition Comprising Antibodies With Anionic Polymer1
Oct 13, 2021Immunoactivating Antigen-Binding Molecule2

Top competitors of Chugai Seiyaku Kabushiki Kaisha

List of top competitors of Chugai Seiyaku Kabushiki Kaisha based on patent oppositions.